Wave Life Net Worth
Wave Life Net Worth Breakdown | WVE |
Wave Life Net Worth Analysis
Wave Life's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Wave Life's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Wave Life's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Wave Life's net worth analysis. One common approach is to calculate Wave Life's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Wave Life's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Wave Life's net worth. This approach calculates the present value of Wave Life's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Wave Life's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Wave Life's net worth. This involves comparing Wave Life's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Wave Life's net worth relative to its peers.
Enterprise Value |
|
To determine if Wave Life is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Wave Life's net worth research are outlined below:
| Wave Life Sciences generated a negative expected return over the last 90 days | |
| Wave Life Sciences has high historical volatility and very poor performance | |
| The company reported the last year's revenue of 108.3 M. Reported Net Loss for the year was (97.01 M) with loss before taxes, overhead, and interest of (51.38 M). | |
| Wave Life Sciences has about 148.16 M in cash with (151.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.71. | |
| Wave Life Sciences has a frail financial position based on the latest SEC disclosures | |
| Over 84.0% of the company outstanding shares are owned by institutional investors | |
| Latest headline from simplywall.st: WuXi AppTec Full Year 2024 Earnings In Line With Expectations |
Wave Life uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Wave Life Sciences. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Wave Life's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 27th of March 2024 Upcoming Quarterly Report | View | |
| 1st of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 27th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Wave Life Target Price Consensus
Wave target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Wave Life's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 10 | Strong Buy |
Most Wave analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Wave stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Wave Life Sciences, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationWave Life Target Price Projection
Wave Life's current and average target prices are 9.67 and 22.30, respectively. The current price of Wave Life is the price at which Wave Life Sciences is currently trading. On the other hand, Wave Life's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Target Price
Analyst Consensus On Wave Life Target Price
Know Wave Life's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Wave Life is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Wave Life Sciences backward and forwards among themselves. Wave Life's institutional investor refers to the entity that pools money to purchase Wave Life's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Vanguard Group Inc | 2024-12-31 | 3.2 M | Emerald Advisers, Llc | 2024-12-31 | 3.2 M | Primecap Management Company | 2024-12-31 | 2.5 M | Geode Capital Management, Llc | 2024-12-31 | 2.5 M | State Street Corp | 2024-12-31 | 2.4 M | Emerald Mutual Fund Advisers Trust | 2024-12-31 | 1.9 M | Artisan Partners Limited Partnership | 2024-12-31 | 1.9 M | Pfizer Inc | 2024-12-31 | 1.9 M | Fmr Inc | 2024-12-31 | 1.8 M | Ra Capital Management, Llc | 2024-12-31 | 18.2 M | Adage Capital Partners Gp Llc | 2024-12-31 | 9.6 M |
Follow Wave Life's market capitalization trends
The company currently falls under 'Mid-Cap' category with a total capitalization of 1.54 B.Market Cap |
|
Project Wave Life's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.28) | (0.29) | |
| Return On Capital Employed | (0.46) | (0.48) | |
| Return On Assets | (0.28) | (0.29) | |
| Return On Equity | (0.46) | (0.49) |
When accessing Wave Life's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Wave Life's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Wave Life's profitability and make more informed investment decisions.
Please note, the presentation of Wave Life's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Wave Life's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Wave Life's management manipulating its earnings.
Evaluate Wave Life's management efficiency
Wave Life Sciences has Return on Asset of (0.22) % which means that on every $100 spent on assets, it lost $0.22. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.7324) %, meaning that it generated no profit with money invested by stockholders. Wave Life's management efficiency ratios could be used to measure how well Wave Life manages its routine affairs as well as how well it operates its assets and liabilities. As of March 21, 2025, Return On Tangible Assets is expected to decline to -0.29. In addition to that, Return On Capital Employed is expected to decline to -0.48. At present, Wave Life's Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Fixed Asset Turnover is expected to grow to 4.06, whereas Other Assets are forecasted to decline to about 4.1 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 1.52 | 1.44 | |
| Tangible Book Value Per Share | 1.52 | 1.44 | |
| Enterprise Value Over EBITDA | (12.99) | (13.64) | |
| Price Book Value Ratio | 8.16 | 15.68 | |
| Enterprise Value Multiple | (12.99) | (13.64) | |
| Price Fair Value | 8.16 | 15.68 | |
| Enterprise Value | 1.4 B | 1.5 B |
The leadership approach at Wave Life's fosters a culture of excellence and accountability. Our analysis examines how this culture influences financial outcomes and stock valuation.
Enterprise Value Revenue 11.6741 | Revenue | Quarterly Revenue Growth 1.882 | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Wave Life insiders, such as employees or executives, is commonly permitted as long as it does not rely on Wave Life's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Wave Life insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Chandra Vargeese over a month ago Acquisition by Chandra Vargeese of 60000 shares of Wave Life at 2.83 subject to Rule 16b-3 | ||
Chandra Vargeese over a month ago Disposition of 46000 shares by Chandra Vargeese of Wave Life at 2.48 subject to Rule 16b-3 | ||
Chandra Vargeese over six months ago Acquisition by Chandra Vargeese of 50000 shares of Wave Life at 10.48 subject to Rule 16b-3 | ||
Adrian Rawcliffe over six months ago Acquisition by Adrian Rawcliffe of 45000 shares of Wave Life at 4.58 subject to Rule 16b-3 | ||
Chandra Vargeese over a year ago Acquisition by Chandra Vargeese of 361700 shares of Wave Life subject to Rule 16b-3 | ||
Ken Takanashi over a year ago Acquisition by Ken Takanashi of 45000 shares of Wave Life subject to Rule 16b-3 | ||
Chandra Vargeese over a year ago Sale by Chandra Vargeese of 10249 shares of Wave Life |
Wave Life Corporate Filings
F4 | 7th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 4th of March 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 14th of February 2025 Other Reports | ViewVerify | |
ASR | 12th of November 2024 Automatic Shelf Registration Statement under Rule 415 filed with the U.S. Securities and Exchange Commission (SEC) | ViewVerify |
Wave Life Earnings Estimation Breakdown
The calculation of Wave Life's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Wave Life is estimated to be -0.2479 with the future projection ranging from a low of -0.29 to a high of -0.2. Please be aware that this consensus of annual earnings estimates for Wave Life Sciences is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-0.29 Lowest | Expected EPS | -0.2 Highest |
Wave Life Earnings Projection Consensus
Suppose the current estimates of Wave Life's value are higher than the current market price of the Wave Life stock. In this case, investors may conclude that Wave Life is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Wave Life's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of March 2025 | Current EPS (TTM) | |
| 11 | 50.0% | 0.27 | -0.2479 | -0.7 |
Wave Life Earnings per Share Projection vs Actual
Actual Earning per Share of Wave Life refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Wave Life Sciences predict the company's earnings will be in the future. The higher the earnings per share of Wave Life, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Wave Life Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Wave Life, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Wave Life should always be considered in relation to other companies to make a more educated investment decision.Wave Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Wave Life's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2025-03-04 | 2024-12-31 | -0.225 | 0.27 | 0.495 | 220 | ||
2024-11-07 | 2024-09-30 | -0.28 | -0.466 | -0.186 | 66 | ||
2024-08-08 | 2024-06-30 | -0.21 | -0.25 | -0.04 | 19 | ||
2024-05-09 | 2024-03-31 | -0.21 | -0.24 | -0.03 | 14 | ||
2024-03-06 | 2023-12-31 | -0.23 | -0.15 | 0.08 | 34 | ||
2023-11-09 | 2023-09-30 | -0.18 | 0.07 | 0.25 | 138 | ||
2023-08-03 | 2023-06-30 | -0.33 | -0.2 | 0.13 | 39 | ||
2023-05-03 | 2023-03-31 | -0.04 | -0.27 | -0.23 | 575 | ||
2023-03-22 | 2022-12-31 | -0.41 | -0.47 | -0.06 | 14 | ||
2022-11-10 | 2022-09-30 | -0.5 | -0.42 | 0.08 | 16 | ||
2022-08-11 | 2022-06-30 | -0.54 | -0.62 | -0.08 | 14 | ||
2022-05-12 | 2022-03-31 | -0.56 | -0.62 | -0.06 | 10 | ||
2022-03-03 | 2021-12-31 | -0.51 | -0.61 | -0.1 | 19 | ||
2021-11-10 | 2021-09-30 | -0.63 | -0.12 | 0.51 | 80 | ||
2021-08-05 | 2021-06-30 | -0.64 | -0.78 | -0.14 | 21 | ||
2021-05-13 | 2021-03-31 | -0.59 | -0.86 | -0.27 | 45 | ||
2021-03-04 | 2020-12-31 | -0.61 | -0.59 | 0.02 | 3 | ||
2020-11-09 | 2020-09-30 | -0.69 | -0.86 | -0.17 | 24 | ||
2020-08-10 | 2020-06-30 | -0.97 | -1.15 | -0.18 | 18 | ||
2020-05-11 | 2020-03-31 | -1.2 | -1.38 | -0.18 | 15 | ||
2020-03-02 | 2019-12-31 | -1.43 | -1.65 | -0.22 | 15 | ||
2019-11-05 | 2019-09-30 | -1.34 | -1.48 | -0.14 | 10 | ||
2019-07-29 | 2019-06-30 | -1.11 | -1.22 | -0.11 | 9 | ||
2019-05-10 | 2019-03-31 | -1.13 | -1.36 | -0.23 | 20 | ||
2019-03-01 | 2018-12-31 | -1.15 | -1.28 | -0.13 | 11 | ||
2018-11-09 | 2018-09-30 | -1.2 | -1.28 | -0.08 | 6 | ||
2018-08-09 | 2018-06-30 | -0.55 | -1.23 | -0.68 | 123 | ||
2018-05-09 | 2018-03-31 | -0.84 | -1.26 | -0.42 | 50 | ||
2018-03-12 | 2017-12-31 | -1 | -1.1 | -0.1 | 10 | ||
2017-11-09 | 2017-09-30 | -0.94 | -0.94 | 0.0 | 0 | ||
2017-08-09 | 2017-06-30 | -0.79 | -0.92 | -0.13 | 16 | ||
2017-05-10 | 2017-03-31 | -0.77 | -0.89 | -0.12 | 15 | ||
2017-03-16 | 2016-12-31 | -0.75 | -0.79 | -0.04 | 5 | ||
2016-11-09 | 2016-09-30 | -0.54 | -0.75 | -0.21 | 38 | ||
2016-08-15 | 2016-06-30 | -0.37 | -0.51 | -0.14 | 37 | ||
2016-05-16 | 2016-03-31 | -0.39 | -0.36 | 0.03 | 7 | ||
2016-03-30 | 2015-12-31 | -0.28 | -0.47 | -0.19 | 67 | ||
2015-12-17 | 2015-09-30 | -0.29 | -0.54 | -0.25 | 86 |
Wave Life Corporate Management
| Kate Rausch | Investor Relations | Profile | |
| Stephen Lake | VP Devel | Profile | |
| Linda JD | Senior Counsel | Profile | |
| Erik MD | Chief Officer | Profile | |
| Sridhar Vaddeboina | Manufacturing Chemistry | Profile | |
| MBA MD | CEO Pres | Profile |
Already Invested in Wave Life Sciences?
The danger of trading Wave Life Sciences is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Wave Life is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Wave Life. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Wave Life Sciences is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Wave Life Sciences is a strong investment it is important to analyze Wave Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Wave Life's future performance. For an informed investment choice regarding Wave Stock, refer to the following important reports: Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Wave Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Wave Life. If investors know Wave will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Wave Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.70) | Revenue Per Share | Quarterly Revenue Growth 1.882 | Return On Assets | Return On Equity |
The market value of Wave Life Sciences is measured differently than its book value, which is the value of Wave that is recorded on the company's balance sheet. Investors also form their own opinion of Wave Life's value that differs from its market value or its book value, called intrinsic value, which is Wave Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Wave Life's market value can be influenced by many factors that don't directly affect Wave Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Wave Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Wave Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Wave Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.